Clinical trial
Celebrex With Preoperative Chemoradiation - Rectal Cancer
NCT00188565 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188565 |
|---|---|
| Title | Celebrex With Preoperative Chemoradiation - Rectal Cancer |
| Official title | A Phase I/II Trial of Celecoxib With Preoperative Chemoradiation for Resectable Rectal Cancer With In Vivo Analysis of Celecoxib Effector Pathways |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Ontario Cancer Research Network Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Enrollment | 39 |
| Start date | Mar 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 13, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: